Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smyth

Showing results (211-220 of 294) with videos related to

Pageof 30
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2011
Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapyD J Storey, D B McLaren, M A Atkinson, et al.
British Journal of Urology|June 1, 1985
Cis-platin and methotrexate in the treatment of transitional cell carcinoma of the urinary tractJ Carmichael, M A Cornbleet, R H MacDougall, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase I and pharmacology study of GR63178A, a water-soluble analogue of mitoquidoneD M Eccles, J Cummings, M E Stewart, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weeklyL K Dawson, D I Jodrell, A Bowman, et al.
Applied Microbiology and Biotechnology|August 14, 2001
Microbial decolourisation and degradation of textile dyesG McMullan, C Meehan, A Conneely, et al.
Lancet (London, England)|December 5, 1981
Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemiaH G Prentice, N H Russell, N Lee, et al.
Cancer Research|December 18, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additivesJeffrey Cummings, Brian T Ethell, Lesley Jardine, et al.
British Journal of Cancer|June 9, 1999
Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell linesK E Wilson, J M Bartlett, E P Miller, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancerS G Allan, A Gregor, M A Cornbleet, et al.
Lancet (London, England)|October 11, 1986
A human tumour modelA P Forrest, P A Levack, U Chetty, et al.
Pageof 30

Showing results (211-220 of 294) with videos related to

Sort By:
Pageof 30
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2011
Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapyD J Storey, D B McLaren, M A Atkinson, et al.
British Journal of Urology|June 1, 1985
Cis-platin and methotrexate in the treatment of transitional cell carcinoma of the urinary tractJ Carmichael, M A Cornbleet, R H MacDougall, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase I and pharmacology study of GR63178A, a water-soluble analogue of mitoquidoneD M Eccles, J Cummings, M E Stewart, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weeklyL K Dawson, D I Jodrell, A Bowman, et al.
Applied Microbiology and Biotechnology|August 14, 2001
Microbial decolourisation and degradation of textile dyesG McMullan, C Meehan, A Conneely, et al.
Lancet (London, England)|December 5, 1981
Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemiaH G Prentice, N H Russell, N Lee, et al.
Cancer Research|December 18, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additivesJeffrey Cummings, Brian T Ethell, Lesley Jardine, et al.
British Journal of Cancer|June 9, 1999
Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell linesK E Wilson, J M Bartlett, E P Miller, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancerS G Allan, A Gregor, M A Cornbleet, et al.
Lancet (London, England)|October 11, 1986
A human tumour modelA P Forrest, P A Levack, U Chetty, et al.
Pageof 30